Akero Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Akero Therapeutics, Inc.‘s stocks are currently a part of 84 hedge funds’ portfolios, which represents 30.34% of the total amount of its stocks outstanding. This makes up a total of 11.82M shares of Akero Therapeutics, Inc.. Compared to the previous quarter, the number fell by -75.68% or -36.80M shares fewer. As for the holding position changes, 34.52% (29) of current hedge fund investors increased the number of shares held, 38.1% (32) of current holders sold a part of the shares held, and 14.29% (12) closed the holdings completely. 10 hedge funds are new holders of Akero Therapeutics, Inc. stock in Q1 2023, it is 11.9% of total holders.
Hedge funds holding Akero Therapeutics (Q2 2019 – Q1 2023)
| Q2 2019 | 48 |
|---|---|
| Q3 2019 | 54 |
| Q4 2019 | 57 |
| Q1 2020 | 67 |
| Q2 2020 | 78 |
| Q3 2020 | 102 |
| Q4 2020 | 94 |
| Q1 2021 | 108 |
| Q2 2021 | 96 |
| Q3 2021 | 102 |
| Q4 2021 | 97 |
| Q1 2022 | 102 |
| Q2 2022 | 111 |
| Q3 2022 | 146 |
| Q4 2022 | 159 |
| Q1 2023 | 84 |
Hedge funds changes in Akero Therapeutics positions (Q2 2019 – Q1 2023)
| Q2 2019 | 48 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2019 | 24 | 13 | 8 | 17 | -8 |
| Q4 2019 | 11 | 24 | 12 | 3 | 7 |
| Q1 2020 | 19 | 23 | 16 | 9 | 0 |
| Q2 2020 | 19 | 33 | 18 | 8 | 0 |
| Q3 2020 | 29 | 40 | 23 | 5 | 5 |
| Q4 2020 | 9 | 38 | 24 | 16 | 7 |
| Q1 2021 | 23 | 29 | 31 | 9 | 16 |
| Q2 2021 | 7 | 43 | 26 | 18 | 2 |
| Q3 2021 | 9 | 28 | 35 | 3 | 27 |
| Q4 2021 | 11 | 30 | 33 | 15 | 8 |
| Q1 2022 | 14 | 34 | 25 | 9 | 20 |
| Q2 2022 | 23 | 39 | 27 | 12 | 10 |
| Q3 2022 | 51 | 52 | 27 | 17 | -1 |
| Q4 2022 | 35 | 69 | 40 | 20 | -5 |
| Q1 2023 | 10 | 29 | 32 | 12 | 1 |
Hedge funds changes in Akero Therapeutics stock options (Q2 2019 – Q1 2023)
| Q2 2019 | 0 | 0 |
|---|---|---|
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 297,000 | 0 |
| Q2 2020 | 0 | 471,000 |
| Q3 2020 | 289,000 | 1,398,000 |
| Q4 2020 | 0 | 1,434,000 |
| Q1 2021 | 2,043,000 | 16,346,000 |
| Q2 2021 | 0 | 3,381,000 |
| Q3 2021 | 0 | 1,887,000 |
| Q4 2021 | 0 | 1,079,000 |
| Q1 2022 | 0 | 326,000 |
| Q2 2022 | 107,000 | 0 |
| Q3 2022 | 17,469,000 | 30,553,000 |
| Q4 2022 | 43,540,160 | 29,270,720 |
| Q1 2023 | 59,000 | 2,559,602,000 |